EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Rise of Enabling Technologies in Pharmaceutical Formulation Development and Manufacturing
Director, Formulation Development, Exelixis, Inc
Kasturi Pawar is a leading pharmaceutical scientist with a PhD in pharmaceutical sciences She has significantly contributed to the field of pharmaceutics Her research and experience have been focused on formulation development drug delivery and clinical supply chain Currently working as a Director in Formulation Development at Exelixis Inc she holds several publications and patents on drug deliver...
Articles
Mussel-inspired Bio-adhesives
Musselinspired bioadhesive gels utilising catecholcontaining compounds provide strongand reversible adhesion to the skin They enhance drug retention enabling sustained releasefor applications in wound healing scar management and targeted transdermal drug delivery in dermatology
Research Insights
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study
Abstract Background Transarterial chemoembolization TACE and sorafenib are the therapeutic standard for intermediate and advanced stage hepatocellular carcinoma HCC patients respectively High costs with adverse events AE of sorafenib might limit sorafenib dosage further affecting therapeutic response To at
Case Studies
External Innovation Implementation Determinants and Performance Measurement: A Case Study from the Pharmaceutical Industry
Abstract With an increasing amount of externally sourced innovations a major success factor for innovationdependent industries such as the pharmaceutical industry is to successfully implement innovations from outside Existing frameworks emphasize creating a strong climate for implementation by developing the learning capabilities of the organization but the
Techno Trends
Accela - Breakthrough technology to increase laboratory productivity by Thermo Fisher
Thermo Fisher Scientific has introduced two new solvent delivery systemsAccela HPLC and Accela UHPLC These enable rapid method development reduce solvent consumption and consequently enhance laboratory efficiency These Accela systems Force Feedback Control FFC features render accurate and precise gradients under all operating conditions and flexibility to quaternary...
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Smart Polymeric Nanocomposites for Cancer Therapeutics
Saurabh Shivalkar is a research fellow at Department of Applied Sciences, IIIT Allahabad, India. He did his M. Tech (Biomedical Engineering) from IIIT Allahabad. He has recently filed patent and published multiple papers in the allied areas of biomedical engineering and nanobiotechnology.
Sneha Ranjan is currently pursuing M.Sc. (Biotechnology) at Department of Biotechnology of Babasaheb Bhimrao Ambedkar University, Lucknow. She has worked on projects such as purification and characterisation of enzyme, production of recombinant proteins for diagnostics and therapeutics. She is currently working on polymeric nanocomposites for cancer therapeutics.
Chronic Wound Healing Properties In Magical Potion Of Lemongrass Herb
Krishnendu Adhikary is working as Assistant Professor and Head of Department of Medical Lab Technology, Paramedical College Durgapur, West Bengal, India. He is working on phytochemical analysis, chronic wound repair. He has published 32 articles, 07 patents. He has received Junior Scientist Award under National Environmental Science Academy (DST, India).
Dr. Pradipta Banerjee is working as a postdoctoral associate in the University of Pittsburgh, USA. He has two years of teaching experience as an Assistant Professor in the Centurion University, India and ten years of research experience. His area of interest is macrophage biology, chronic wound healing and tissue regeneration.
Beyond the Cold Chain
Dr. Mary Manoranjani Addanki, PhD, is an Associate Professor and Head of Pharmaceutics at Malla Reddy College of Pharmacy. With 17 years of expertise, she specialises in nanotechnology, pulmonary vaccines, and advanced drug delivery. An award-winning researcher and patent holder, her work focuses on stabilising vaccines and developing innovative dosage forms.
AI Cures
Anuradha Singh is an Assistant professor at the Department of Chemistry, S Khanna Girls’ Degree College, University of Allahabad. She is well versed in synthetic chemistry, computer-aided drug design and other techniques used in the field of medicinal chemistry. Dr Singh has published more than 30 research papers/book chapters, in addition to several articles, in journals/books of national and international repute. She has been selected for the prestigious Indian National Science Academy's Visiting Scientist fellowship in 2023. She is a member of several national bodies and referee to various national/ international journals. She successfully led research projects funded by DST and UGC, demonstrating strong leadership and project management skills.
Quercetin - A Super Food For Therapeutic Interventions
Mohini Sikarwar is a PhD Scholar at Centre for Development of Biomaterials, Sharda University, Greater Noida, India. Her research is focusing on advanced drug delivery systems with a commitment to enhancing therapeutic efficacy of poorly water-soluble drug for Leishmaniasis treatment. She is aiming to revolutionise the current treatment methods of Kala azar using drug delivery approaches.
Dr. Piyush Kumar Gupta is currently head of the Centre for Development of Biomaterials at Sharda University, Greater Noida, India. His area of expertise belongs to Biomaterials, Pharmaceutics, and Nanotoxicology. He has published 143 SCIE and Scopus-indexed peer-reviewed articles and 7 book chapters in his area of expertise. He has been bestowed with several International or National awards.
press releasesRead more...
Introducing Cognizant® Patient Hub Operations: AI-enabled patient access offering designed to shorten the path from prescription to therapy
Cognizant Nasdaq CTSH today introduced Cognizant Patient Hub Operations an offering built on NVIDIA accelerated computing that pairs AI agents with healthcareexperienced specialists to support patients and help drive better access to therapy
Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production
Thermo Fisher Scientific the world leader in serving science today announced the Gibco VaxEvo CD Medium a chemically defined and animal originfree medium designed to support suspension HEK cell growth and hightiter adenovirus production
Purdue and Evonik launch strategic partnership in pharmaceutical manufacturing
Purdue University is launching a new industry partnership with Evonik one of the worlds leading specialty chemicals companies The partnership agreement lays the groundwork for sponsored research product and technology development manufacturing collaboration and workforce and economic development
Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals
Genomics a scienceled Techbio company using largescale genetic information to develop innovative precision healthcare tools and to accelerate drug discovery and development today announced a fouryear extension of its longstanding drug target discove
22nd Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech
Pharma organisations are still in a transition process from traditional model centered on blockbuster to more collaborative global ones In order to address the main challenge of RD productivity PPM professional serve as a link between operational teams and senior management level They have the role...
Takeda and Zuellig Pharma Announce Strategic Regional Collaboration to Expand Patient Access to Takeda's Innovative Medicines Across Southeast Asia
Takeda and Zuellig Pharma today announced a strategic regional collaboration to enhance sustainable patient access to innovative medicines and healthcare solutions across Malaysia Indonesia and the Philippines Effective December the collaboration
EventsRead more...
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
03 - 04
Dec 2026Pharmacy and Pharmaceutical Conference
Madrid, Spain
03 - 04
Dec 2026Infectious and Rare Diseases
Paris, France
LATEST NEWSRead more...
Sanofi Receives Approval for Infilbray to Treat Neurological Symptoms of Type 3 Gaucher Disease
Sanofi has received approval from the US Food and Drug Administration FDA for Infilbray venglustat an oral medicine for treating neurological manifestations of Type Gaucher disease GD in adults and children weighing at least kg
Pfizer Enters into Agreement with Starna Therapeutics for Autoimmune Disease Treatments
Pfizer has entered into an exclusive licensing agreement with biotechnology company Starna Therapeutics to develop RNAbased in vivo chimeric antigen receptor Tcell CART therapies for autoimmune diseases
OXB Partners with Aura Biosciences for Drug Manufacturing
OXB has confirmed a manufacturing and supply partnership with Aura Biosciences
GSK Receives Approval for Nelkarmi to Treat Advanced ALK-Positive Lung Cancer
GSK plc LSENYSE GSK has received accelerated approval from the US Food and Drug Administration FDA for Nelkarmi neladalkib a treatment for adults with locally advanced or metastatic anaplastic lymphoma kinase ALKpositive nonsmall cell lung cancer NSCLC
Erasca Enters into Collaboration with Bristol Myers Squibb to Evaluate Pancreatic Cancer Therapy
Erasca has entered into a clinical trial collaboration and supply agreement with Bristol Myers to evaluate the combination of ERAS and navlimetostat BMS an investigational PRMT inhibitor in patients with pancreatic cancer
OBI Pharma and Novartis Partner to Develop Next-Generation ADCs for Cancer Treatment
OBI Pharma has entered into a collaboration and licensing agreement with Novartis to develop nextgeneration antibodydrug conjugates ADCs using novel payloads and OBIs proprietary technology platforms


